A multi-country observational study for efficacy of DuoResp R Spiromax R in patients with asthma and COPD in Europe
Latest Information Update: 19 Apr 2021
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms SPRINT
- 19 Apr 2021 New trial record